A detailed history of Schonfeld Strategic Advisors LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 25,900 shares of MRVI stock, worth $135,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,900
Holding current value
$135,198
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.84 - $9.73 $177,156 - $252,007
25,900 New
25,900 $215,000
Q1 2024

May 15, 2024

SELL
$5.11 - $8.76 $205,953 - $353,063
-40,304 Reduced 71.84%
15,796 $136,000
Q4 2023

Feb 14, 2024

BUY
$4.7 - $9.87 $263,670 - $553,707
56,100 New
56,100 $367,000
Q2 2023

Aug 14, 2023

BUY
$12.09 - $15.0 $142,662 - $177,000
11,800 New
11,800 $146,000
Q4 2022

Feb 14, 2023

BUY
$12.5 - $24.78 $444,100 - $880,383
35,528 New
35,528 $508,000
Q2 2022

Aug 15, 2022

SELL
$26.05 - $37.48 $1.61 Million - $2.32 Million
-61,800 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$24.46 - $40.92 $174,008 - $291,104
-7,114 Reduced 10.32%
61,800 $2.18 Million
Q4 2021

Feb 14, 2022

BUY
$35.0 - $45.94 $1.96 Million - $2.57 Million
55,904 Added 429.7%
68,914 $2.89 Million
Q3 2021

Nov 16, 2021

SELL
$36.8 - $60.62 $302,532 - $498,357
-8,221 Reduced 38.72%
13,010 $639,000
Q2 2021

Aug 16, 2021

SELL
$32.46 - $45.0 $664,423 - $921,105
-20,469 Reduced 49.09%
21,231 $886,000
Q1 2021

May 17, 2021

BUY
$25.8 - $38.49 $541,929 - $808,482
21,005 Added 101.5%
41,700 $1.49 Million
Q4 2020

Feb 16, 2021

BUY
$24.5 - $30.86 $507,027 - $638,647
20,695 New
20,695 $580,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $687M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.